Market Valuation: hcwbiologics.com (HCWB)
The price history of HCW Biologics Inc. (HCWB) on the GURU.Markets platform, where the market capitalization stands at 0.00, coincides with strict adherence to medical regulations and environmental laboratory controls. The company's revenues rely on cytokine immunotherapy targeting oncology and age-related pathologies. The brand is valued in gerontology for its pursuit of longevity secrets, developing cutting-edge methods to combat cancer and age-related bodily changes.
Comprehensive metric breakdowns and analytics for hcwbiologics.com (HCWB)
- current price and projected stock value:
- company stock exchange capitalization indicators:
- business book valuation details:
- debt level and financial liquidity data:
Total Debt to Capital HCW Biologics Inc.|HCWB - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital HCW Biologics|HCWB - Company Aggregate Debts|Debt to Book Capitalization Ratio HCW Biologics|HCWB - Company Long-Term Loans and Borrowings|Company Short-Term Debt HCW Biologics|Quick Ratio hcwbiologics.com
- financial results and valuation multiples details:
HCWB - Net Profit|Future Profit HCW Biologics Inc.|HCWB - Company Value to Net Income|Forward P/E Multiple HCW Biologics|HCWB - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HCW Biologics|HCWB - Operating profit before deduction of amortization|Earnings per share for the last twelve months HCW Biologics|HCWB - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months hcwbiologics.com|HCWB - Earnings growth in current year|Net earnings per share growth forecast for next year HCW Biologics Inc.
Fundamental company analysis:HCWB (HCW Biologics Inc)
Market capitalization reflects the total value of all shares, allowing for an objective assessment of business scale and its volatility relative to the index. This metric filters out market noise to determine the asset's real value. Analyzing the issuer's total capitalization with a current value of 0.00 helps identify whether the company is overvalued or undervalued. For HCW Biologics Inc. (HCWB), this indicator balances R&D expenditures against stringent FDA oversight. Patents for TOBI platforms provide a fundamental support for the valuation.
Key competitors
Market Capitalization ARGX (argenx)|BNTX - Market Valuation|ABVX: Market Valuation|ADMA Corp (ADMA) - Market Valuation|PTGX: Market Capitalization|IMVT (immunovant.com) - Market Value|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KalVista Pharmaceuticals, Inc. (KALV) - Market Value|Market Valuation Septerna, Inc.|Market Valuation PVLA|Market Capitalization Savara Pharma|Market Value Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Market Capitalization|Market Capitalization ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Market Value|RAPT Therapeutics - Market Capitalization|Market Value JBIO (Aerovate Therapeutics Inc)|ACRS: Market Capitalization|Market Valuation kyvernatx.com|Market Valuation TLSA|Market Valuation Cabaletta Bio Inc. (CABA)|Market Valuation VTYX (Ventyx Bio)|THTX (Theratechnologies, Inc) - Market Value|Market Capitalization AVTX (Avalo Therapeutics, Inc)|eledon.com - Market Value|Agenus Inc. - Market Capitalization|Market Capitalization Climb Bio Inc. CLYM|Zura Bio (ZURA) - Market Value|Market Value aTyr Pharmaceuticals (ATYR)|Market Value Adagene Inc|Market Value IMA|Market Value Shattuck Labs, Inc. (STTK)|EQ - Market Value|Market Capitalization CNTB (Connect Biopharma Holdings Limited)|Market Capitalization Immunic Therapeutics|Atara Biotherapeutics Inc - Market Capitalization|Market Capitalization InflaRx N.V. IFRX|XFOR: Market Capitalization|Market Valuation Adicet Bio, Inc.|Market Value Celularity Inc|INmune Bio Corporation (INMB) - Market Capitalization|Market Valuation BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Market Value|Market Capitalization SABS (SAB Biotherapeutics, Inc.)|Market Capitalization Akari Therapeutics PLC (AKTX)|ENLV - Market Value|QTTB (Q32 Bio Inc.) - Market Capitalization|GOVX: Market Capitalization|Market Valuation edesabiotech.com|Market Valuation IBIO|Carisma Tx (CARM) - Market Capitalization|Market Capitalization XTLB|BOLT (boltbio.com) - Market Value|Market Capitalization APVO (Aptevo Therapeutics Inc.)|AIM - Market Valuation|ADTX: Market Valuation|GRI Bio Inc (GRI) - Market Valuation|XRTX: Market Capitalization|HIND (Vyome Therapeutics) - Market Value|Market Value Revelation Biosciences|indaptusrx.com - Market Valuation|Market Capitalization SCNI|CALI (calcimedica.com) - Market Value|Market Capitalization AFMD (Affimed N.V.)|Market Capitalization Allakos Inc ALLK|HOOK - Market Value|Market Value IGMS (IGM Biosciences, Inc.)|iTeos Therapeutics, Inc. (ITOS) - Market Value|Market Valuation Ocean Biomedical Inc|TCBP (TC BioPharm (Holdings) PLC) - Market Capitalization|Market Capitalization Third Harmonic Bio Inc
